Geron | GERN - Current Assets

Stock Price
1.30
Daily Change
-0.11 -7.50%
Monthly
-23.37%
Yearly
1.97%
Q2 Forecast
1.36

Geron reported $498.53M in Current Assets for its fiscal quarter ending in March of 2026.





Current Assets Change Date
Amgen USD 31.48B 2.42B Mar/2026
Bio Techne USD 688.05M 50.62M Mar/2026
Cassava Sciences USD 87.96M 9.74M Mar/2026
Cytokinetics USD 839.46M 77.51M Mar/2026
Esperion Therapeutics USD 459.46M 3.11M Mar/2026
Exelixis USD 1.21B 234.65M Mar/2026
Genmab DKK 2.88B 1.59B Dec/2025
Geron USD 498.53M 21.74M Mar/2026
Gilead Sciences USD 18.64B 1.25B Mar/2026
Incyte USD 5.48B 460.36M Mar/2026
MacroGenics USD 182.52M 37.42M Mar/2026
Novartis USD 26.61B 3.85B Mar/2026
Novavax USD 850.82M 127.46M Mar/2026